M D Saju1,2, Bindiya M Varghese3, Lorane Scaria4,5, Anuja Maria Benny4,5, Shilpa V Yohannan4,5, Natania Cheguvera4,5, S P Rajeev6, Amuthavalli Thiyagarajan Jotheeswaran7,8. 1. Department of Social Work, Rajagiri International Centre for Consortium Research in Social Care, Kalamassery, Kochi, Kerala, India. saju@rajagiri.edu. 2. Rajagiri College of Social Sciences (Autonomous), Rajagiri P.O, Kalamassery, Kochi, Kerala, 683 104, India. saju@rajagiri.edu. 3. Department of Computer Science, Rajagiri College of Social Sciences (Autonomous), Kalamassery, Kochi, Kerala, India. 4. Rajagiri College of Social Sciences (Autonomous), Rajagiri P.O, Kalamassery, Kochi, Kerala, 683 104, India. 5. Rajagiri International Centre for Consortium Research in Social Care, Kalamassery, Kochi, Kerala, India. 6. Department of Social Work, Rajagiri College of Social Sciences (Autonomous), Kalamassery, Kochi, Kerala, India. 7. Department of Ageing and Life Course, WHO, Geneva, GE, Switzerland. 8. Institute of Psychiatry, Psychology and Neurosciences, King's College London, London, UK.
Abstract
BACKGROUND: Kerala is known as the diabetes mellitus (DM) and hypertension (HTN) capital of the world, thus compelling health professionals to model strategies, addressing their social, behavioural, and cognitive risk factors and eliminating various barriers to management. This paper describes the protocol of our study that aims to examine the effectiveness and sustainability of an integrated care model for the management of chronic conditions and their risk factors through a family-based intervention. The proposed care model targets to modify systems and processes that predispose to chronic conditions by enhancing social cohesion and social networks, preventing lifestyle risks, developing iterative cognitive interventions, and engaging the family into customised treatment adherence strategies navigated by community health social workers (CHSWs). METHODS: A cluster randomised controlled trial (RCT) in selected participants will be conducted involving additional assessments prior to the baseline assessment. The assessment will identify and categorise patients into four risk groups, namely behavioural, social, cognitive, and multiple, based on dominant risks identified. Eligible participants will be randomly allocated (at a ratio of 1:1) into the intervention or control arm. The intervention arm will receive social, behavioural, and cognitive or multiple interventions corresponding to the identified risk groups, whereas the control arm will receive general intervention. Both the groups will be followed up at 6 months and 12 months post baseline to measure outcomes. The primary outcome will be the control of HTN and DM, and secondary outcomes include decreased depression and anxiety and improved functioning, social cohesion, and social network linkages. The sustainability and scalability of this intervention will be assessed through cost effectiveness, acceptability, and user friendliness of the integrated approach by performing a qualitative evaluation. DISCUSSION: This RCT will inform the potential paradigm shift from a medical model of chronic condition management to a multidimensional, multisystem, and multidisciplinary convergence model navigated by CHSWs. Such a model is not currently considered in the management of chronic conditions in Kerala. TRIAL REGISTRATION: Trial has been prospectively registered on Clinical Trial Registry of India- CTRI/2020/12/029474 on 1st December 2020.
RCT Entities:
BACKGROUND: Kerala is known as the diabetes mellitus (DM) and hypertension (HTN) capital of the world, thus compelling health professionals to model strategies, addressing their social, behavioural, and cognitive risk factors and eliminating various barriers to management. This paper describes the protocol of our study that aims to examine the effectiveness and sustainability of an integrated care model for the management of chronic conditions and their risk factors through a family-based intervention. The proposed care model targets to modify systems and processes that predispose to chronic conditions by enhancing social cohesion and social networks, preventing lifestyle risks, developing iterative cognitive interventions, and engaging the family into customised treatment adherence strategies navigated by community health social workers (CHSWs). METHODS: A cluster randomised controlled trial (RCT) in selected participants will be conducted involving additional assessments prior to the baseline assessment. The assessment will identify and categorise patients into four risk groups, namely behavioural, social, cognitive, and multiple, based on dominant risks identified. Eligible participants will be randomly allocated (at a ratio of 1:1) into the intervention or control arm. The intervention arm will receive social, behavioural, and cognitive or multiple interventions corresponding to the identified risk groups, whereas the control arm will receive general intervention. Both the groups will be followed up at 6 months and 12 months post baseline to measure outcomes. The primary outcome will be the control of HTN and DM, and secondary outcomes include decreased depression and anxiety and improved functioning, social cohesion, and social network linkages. The sustainability and scalability of this intervention will be assessed through cost effectiveness, acceptability, and user friendliness of the integrated approach by performing a qualitative evaluation. DISCUSSION: This RCT will inform the potential paradigm shift from a medical model of chronic condition management to a multidimensional, multisystem, and multidisciplinary convergence model navigated by CHSWs. Such a model is not currently considered in the management of chronic conditions in Kerala. TRIAL REGISTRATION: Trial has been prospectively registered on Clinical Trial Registry of India- CTRI/2020/12/029474 on 1st December 2020.
Entities:
Keywords:
Diabetes mellitus; Hypertension; India; Integrated care model; Medical compliance; Study protocol
Authors: Rajesh Vedanthan; Sameer Bansilal; Ana Victoria Soto; Jason C Kovacic; Jacqueline Latina; Risa Jaslow; Maribel Santana; Elio Gorga; Andrew Kasarskis; Roger Hajjar; Eric E Schadt; Johan L Björkegren; Zahi A Fayad; Valentin Fuster Journal: J Am Coll Cardiol Date: 2016-04-12 Impact factor: 24.094
Authors: Craig J Currie; Mark Peyrot; Christopher Ll Morgan; Chris D Poole; Sara Jenkins-Jones; Richard R Rubin; Christopher M Burton; Marc Evans Journal: Diabetes Care Date: 2012-04-17 Impact factor: 19.112
Authors: Panniyammakal Jeemon; S Harikrishnan; G Sanjay; Sivasankaran Sivasubramonian; T R Lekha; Sandosh Padmanabhan; Nikhil Tandon; Dorairaj Prabhakaran Journal: BMC Public Health Date: 2017-01-05 Impact factor: 3.295